Daniel Cantillon News Today

Device provided atrial pacing, reliable atrioventricular synchrony for 3 months post-implantation

This strongly supports “going extravascular for defibrillators as opposed to transvenous systems,” one expert says.

Abbott has taken a major step in the development of its dual-chamber leadless pacemaker technology, with the company’s first patient receiving two miniaturized, wirelessly synced devices in different areas of the heart.

The first two systems were successfully implanted last week.

The first two systems were successfully implanted last week.

A phase 2 study shows promising benefits and safety with a new leadless pacemaker, delivering effective right ventricular pacing with a retrievable device.

The Cleveland Clinic says the device integrates wireless communication between leadless pacing and defibrillator therapy.

As part of a global clinical trial, the Clinic has successfully implanted the novel device, which integrates wireless communication between leadless pacing and defibrillator therapy.

Heart rate can be a key indicator of your health, but cardiologists emphasize that it’s just “one piece of the puzzle.”

February 10, 2021 Upgrading a patient from an existing permanent pacemaker or implantable cardioverter-defibrillator (ICD) to a cardiac resynchronization therapy (CRT) device can be successfully and safely done in the hands of experienced operators, according to a new analysis from a large tertiary center. When compared with patients undergoing de novo CRT implantation, the rates of procedural success and complications at 90 days were similar in patients undergoing the procedure for an upgrade...